Vidac Pharma Holding (STU:T9G) FCF Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vidac Pharma Holding's Free Cash Flow for the six months ended in Jun. 2024 was €-0.53 Mil. Vidac Pharma Holding's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Vidac Pharma Holding's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Vidac Pharma Holding's current FCF Yield % is -3.99%.

The historical rank and industry rank for Vidac Pharma Holding's FCF Margin % or its related term are showing as below:

STU:T9G's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -143.22
* Ranked among companies with meaningful FCF Margin % only.

Vidac Pharma Holding FCF Margin % Historical Data

The historical data trend for Vidac Pharma Holding's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidac Pharma Holding FCF Margin % Chart

Vidac Pharma Holding Annual Data

Trend

Dec21

Dec22

Dec23

FCF Margin %

Vidac Pharma Holding Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	-	-	-	-	-

Competitive Comparison of Vidac Pharma Holding's FCF Margin %

For the Biotechnology subindustry, Vidac Pharma Holding's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vidac Pharma Holding's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vidac Pharma Holding's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vidac Pharma Holding's FCF Margin % falls into.

Vidac Pharma Holding FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vidac Pharma Holding's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.792	/	0
	=	%

Vidac Pharma Holding's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-0.528	/	0
	=	%

Vidac Pharma Holding FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vidac Pharma Holding's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vidac Pharma Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Wenlock Road, 20-22, London, GBR, N1 7GU

Website

https://www.vidacpharma.com

Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.

Vidac Pharma Holding Headlines

No Headlines